Evidence map›Paper›PMID 40531445›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Synthesis of Bicyclic Peptides Using Cyanopyridine-Aminothiol Click Chemistry.

Sven Ullrich, Christoph Nitsche

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sven UllrichResearch School of Chemistry, Australian National University, Canberra, ACT, Australia.ORCID https://orcid.org/0000-0003-4184-7024
Christoph NitscheResearch School of Chemistry, Australian National University, Canberra, ACT, Australia. christoph.nitsche@anu.edu.au.ORCID https://orcid.org/0000-0002-3704-2699

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Constrained peptides are emerging as promising structures in therapeutic development. Offering compatibility with genetically encoded libraries for drug discovery, biocompatible methods to constrain peptides are particularly attractive. While there are many such methods to construct cyclic and stapled peptides, the biocompatible generation of bicyclic peptides is less explored. Addressing this need for biocompatible and selective ways to generate peptide bicycles, we previously developed a strategy based on noncanonical amino acids leveraging the reactivity of cyanopyridine and 1,2-aminothiol. This protocol provides detailed step-by-step instructions for the synthesis of these peptide bicycles and is designed to be accessible even to laboratories with limited synthetic chemistry resources. It outlines the solid-phase peptide synthesis of linear peptide precursors that efficiently form bicyclic structures in aqueous buffer at physiological pH. Utilizing commercially available building blocks, we devised a method to synthesize the noncanonical amino acids that are essential for bicyclization directly on the solid support during peptide synthesis.

Indexed as

Click ChemistryPeptides, CyclicPyridinesSulfhydryl CompoundsAmino AcidsSolid-Phase Synthesis TechniquesAmino AcidsPeptides, CyclicPyridinesSulfhydryl CompoundsBiocompatible chemistryConstrained peptidesNoncanonical amino acidsPeptide macrocyclizationSolid-phase peptide synthesis

Identifiers

PMID40531445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.